T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.4% |
| 2 | Healthcare | 16.1% |
| 3 | Consumer Discretionary | 15.8% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Coherent
COHR
$65.4B
| $2.81M | ﹤0.01% |
41,101
-10,589
| -20% | -$666K |
|
1602
Strategy Inc
MSTR
$36.5B
| $2.81M | ﹤0.01% |
51,580
+7,240
| +16% | +$498K |
|
|
CIT
1603
DELISTED
CIT Group Inc.
CIT
| $2.78M | ﹤0.01% |
54,216
-2,863
| -5% | -$146K |
|
1604
Simpson Manufacturing
SSD
$7.92B
| $2.71M | ﹤0.01% |
19,458
-1,027
| -5% | -$124K |
|
1605
Ramaco Resources Class A
METC
$728M
| $2.69M | ﹤0.01% |
+204,165
| New | +$2.65M |
|
1606
Carter's
CRI
$1.43B
| $2.66M | ﹤0.01% |
26,315
-2,057
| -7% | -$210K |
|
1607
Prestige Consumer Healthcare
PBH
$2.41B
| $2.65M | ﹤0.01% |
43,760
+4,431
| +11% | +$263K |
|
1608
Arrow Electronics
ARW
$10.8B
| $2.65M | ﹤0.01% |
19,753
-1,313
| -6% | -$161K |
|
1609
Thor Industries
THO
$4.11B
| $2.65M | ﹤0.01% |
25,550
+933
| +4% | +$101K |
|
1610
iShares Russell 2000 ETF
IWM
$82.7B
| $2.65M | ﹤0.01% |
11,907
+778
| +7% | +$176K |
|
1611
Asana
ASAN
$2.14B
| $2.63M | ﹤0.01% |
35,270
-19,813
| -36% | -$2.1M |
|
|
NSA
1612
DELISTED
National Storage Affiliates Trust
NSA
| $2.61M | ﹤0.01% |
37,718
+761
| +2% | +$47K |
|
1613
Safety Insurance
SAFT
$1.52B
| $2.61M | ﹤0.01% |
30,685
-144,110
| -82% | -$11.6M |
|
1614
Starwood Property Trust
STWD
$6.11B
| $2.6M | ﹤0.01% |
107,133
-7,302
| -6% | -$184K |
|
1615
Toll Brothers
TOL
$13.8B
| $2.6M | ﹤0.01% |
35,870
-1,822
| -5% | -$117K |
|
|
SNV
1616
DELISTED
Synovus
SNV
| $2.6M | ﹤0.01% |
54,236
-2,452
| -4% | -$116K |
|
1617
Valley National Bancorp
VLY
$8.34B
| $2.59M | ﹤0.01% |
188,505
-6,736
| -3% | -$93.5K |
|
|
MNDT
1618
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $2.58M | ﹤0.01% |
147,341
+56,249
| +62% | +$988K |
|
1619
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.8B
| $2.56M | ﹤0.01% |
+49,760
| New | +$2.59M |
|
1620
First Financial Bankshares
FFIN
$5.06B
| $2.55M | ﹤0.01% |
50,095
-1,552
| -3% | -$78.8K |
|
1621
Nutanix
NTNX
$18B
| $2.54M | ﹤0.01% |
79,741
-5,249
| -6% | -$180K |
|
|
STFC
1622
DELISTED
State Auto Financial Corp
STFC
| $2.54M | ﹤0.01% |
49,146
+4,846
| +11% | +$249K |
|
1623
Bank of Montreal
BMO
$129B
| $2.53M | ﹤0.01% |
23,458
-2
| -0% | -$216 |
|
1624
Cousins Properties
CUZ
$4.9B
| $2.52M | ﹤0.01% |
62,691
-2,400
| -4% | -$94.5K |
|
1625
Arcos Dorados Holdings
ARCO
$1.71B
| $2.52M | ﹤0.01% |
432,175
+58,648
| +16% | +$298K |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.